• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA 系统的 DRB1*11 和 DRB1*12 等位基因与布基纳法索乙型肝炎病毒感染的演变有关。

Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso.

机构信息

Laboratoire de Biologie Moléculaire Et de Génétique, Université Joseph KI-ZERBO, P.O. Box 7021, Ouagadougou 03, Burkina Faso.

Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), P.O. Box 364, Ouagadougou 01, Burkina Faso.

出版信息

Mol Biol Rep. 2023 Jun;50(6):5039-5047. doi: 10.1007/s11033-023-08353-0. Epub 2023 Apr 26.

DOI:10.1007/s11033-023-08353-0
PMID:37101005
Abstract

BACKGROUND

Hepatitis B Virus (HBV) infection affect all social strata of humanity and in the absence of any management, this infection has a different outcome from one infected person to another. This suggests that there are specific individual factors that influence the outcome of the pathology. Sex, immunogenetics and age of contraction of the virus have been cited as factors that influence the evolution of the pathology. In this study, we looked at two alleles of the Human Leucocyte Antigen (HLA) system to measure their possible involvement in the evolution of HBV infection.

METHOD AND RESULTS

We conducted a cohort study involving 144 individuals spread over 04 distinct stages of infection and then compared allelic frequencies in these populations. A multiplex PCR was conducted and the data obtained was analyzed using R and SPSS software. Our study revealed a predominance of HLA-DRB112 in our study population without, however, showing a significant difference between HLA-DRB111 and HLA-DRB112. The HLA-DRB112 proportion was significantly higher in chronic hepatitis B (CHB) and resolved hepatitis B (RHB) compared to cirrhosis and hepatocellular carcinoma (HCC) (p-value = 0,002). Carrying HLA-DRB112 has been associated with a low risk of complication of infection (CHB → cirrhosis; OR 0,33 p-value 0,017; RHB → HCC OR 0,13; p-value = 0,00,045) whereas the presence of HLA-DRB111 in the absence of HLA-DRB1*12 increased the risk of developing severe liver disease. However, a strong interaction of these alleles with the environment could modulate the infection.

CONCLUSION

Our study shown that HLA-DRB1*12 is the most frequent and it's carriage may be protective in the development of infection.

摘要

背景

乙型肝炎病毒(HBV)感染影响人类的所有社会阶层,在没有任何管理的情况下,这种感染在一个感染者和另一个感染者之间有不同的结果。这表明存在影响病理学结果的特定个体因素。性别、免疫遗传学和病毒感染的年龄已被认为是影响病理学演变的因素。在这项研究中,我们研究了人类白细胞抗原(HLA)系统的两个等位基因,以衡量它们在 HBV 感染演变中的可能作用。

方法和结果

我们进行了一项队列研究,涉及 144 名分布在感染的 04 个不同阶段的个体,然后比较了这些人群中的等位基因频率。进行了多重 PCR,并用 R 和 SPSS 软件分析了获得的数据。我们的研究表明,在我们的研究人群中 HLA-DRB112 占主导地位,但 HLA-DRB111 和 HLA-DRB112 之间没有显著差异。与肝硬化和肝细胞癌(HCC)相比,慢性乙型肝炎(CHB)和已解决的乙型肝炎(RHB)中 HLA-DRB112 的比例显著更高(p 值=0.002)。携带 HLA-DRB112 与感染并发症的风险降低相关(CHB→肝硬化;OR 0.33,p 值 0.017;RHB→HCC,OR 0.13,p 值=0.00045),而在没有 HLA-DRB112 的情况下存在 HLA-DRB1*11 则增加了发生严重肝病的风险。然而,这些等位基因与环境的强烈相互作用可能会调节感染。

结论

我们的研究表明,HLA-DRB1*12 是最常见的,其携带可能对感染的发展具有保护作用。

相似文献

1
Association of DRB1*11 and DRB1*12 alleles of the HLA system with the evolution of the Hepatitis B virus infection in Burkina Faso.HLA 系统的 DRB1*11 和 DRB1*12 等位基因与布基纳法索乙型肝炎病毒感染的演变有关。
Mol Biol Rep. 2023 Jun;50(6):5039-5047. doi: 10.1007/s11033-023-08353-0. Epub 2023 Apr 26.
2
Relationship of HLA-DRB1 alleles with hepatocellular carcinoma development in chronic hepatitis B patients.HLA-DRB1 等位基因与慢性乙型肝炎患者肝细胞癌发展的关系。
J Clin Gastroenterol. 2012 May-Jun;46(5):420-6. doi: 10.1097/MCG.0b013e318239f9cc.
3
The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.下调 HLA-DRB1 增强子活性的遗传多态性有助于中国汉族人群中 HBV 的持续存在、进化和肝癌发生。
J Viral Hepat. 2020 Nov;27(11):1150-1161. doi: 10.1111/jvh.13353. Epub 2020 Jul 7.
4
/ Alleles Associate with Traditional Chinese Medicine Syndrome of Chronic Hepatitis B: A Potential Predictor of Progression./ 等位基因与慢性乙型肝炎中医证候相关:疾病进展的潜在预测指标。
Biomed Res Int. 2019 Nov 21;2019:8146937. doi: 10.1155/2019/8146937. eCollection 2019.
5
Association of human leukocyte antigen-DRB1 alleles with chronic hepatitis B virus infection in the Han Chinese of Northeast China.东北地区汉族人群人类白细胞抗原-DRB1 等位基因与慢性乙型肝炎病毒感染的相关性。
Mol Med Rep. 2012 May;5(5):1347-51. doi: 10.3892/mmr.2012.800. Epub 2012 Feb 20.
6
Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.泰国人群中HLA-DRB1*13和肿瘤坏死因子-α基因多态性与慢性乙型肝炎感染清除及肝细胞癌风险的关联
J Viral Hepat. 2007 Dec;14(12):841-8. doi: 10.1111/j.1365-2893.2007.00880.x.
7
The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China.中国东北地区 HLA 等位基因和 HBV 亚型对乙型肝炎病毒感染结局的影响。
Virus Res. 2012 Jan;163(1):328-33. doi: 10.1016/j.virusres.2011.10.020. Epub 2011 Oct 25.
8
Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.人类白细胞抗原DQ基因多态性及其与乙型肝炎病毒突变的相互作用对病毒持续存在、肝硬化和肝细胞癌风险的影响。
Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2.
9
HLA-class II alleles in Egyptian patients with hepatocellular carcinoma.埃及肝细胞癌患者的人类白细胞抗原II类等位基因
Immunol Invest. 2008;37(7):661-74. doi: 10.1080/08820130802111605.
10
[Association of polymorphism on HLA-DRB1*04 alleles with outcome of hepatitis B virus infection].[HLA-DRB1*04等位基因多态性与乙型肝炎病毒感染结局的关联]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Aug;24(4):467-9.

引用本文的文献

1
Molecular Analysis of HLA Genes in Romanian Patients with Chronic Hepatitis B Virus Infection.罗马尼亚慢性乙型肝炎病毒感染患者HLA基因的分子分析
Curr Issues Mol Biol. 2024 Jan 24;46(2):1064-1077. doi: 10.3390/cimb46020067.

本文引用的文献

1
Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis.HLA-DR 基因多态性与乙型肝炎病毒感染结局的关系:荟萃分析。
World J Gastroenterol. 2012 Jun 28;18(24):3119-28. doi: 10.3748/wjg.v18.i24.3119.
2
Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.HLA-DRB1 等位基因多态性与肝细胞癌的关系:荟萃分析。
BMC Gastroenterol. 2010 Dec 21;10:145. doi: 10.1186/1471-230X-10-145.
3
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
乙型肝炎病毒(HBV)相关肝细胞癌(HCC):分子机制与新范式
Pathol Biol (Paris). 2010 Aug;58(4):278-87. doi: 10.1016/j.patbio.2010.05.001. Epub 2010 Jul 27.
4
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.乙肝e抗原阴性乙肝表面抗原携带者的长期预后与丙氨酸氨基转移酶水平随时间的变化关系
Hepatology. 2009 Jun;49(6):1859-67. doi: 10.1002/hep.22878.
5
Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection.人类白细胞抗原多态性与乙型肝炎病毒感染结局的关联
J Gastroenterol Hepatol. 2008 Nov;23(11):1716-21. doi: 10.1111/j.1440-1746.2008.05482.x. Epub 2008 Aug 28.
6
A comparative review of HLA associations with hepatitis B and C viral infections across global populations.全球人群中HLA与乙型和丙型病毒感染相关性的比较综述
World J Gastroenterol. 2007 Mar 28;13(12):1770-87. doi: 10.3748/wjg.v13.i12.1770.
7
Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients.人类白细胞抗原II类基因与乙型肝炎病毒感染易感性及乙肝病毒感染患者对干扰素反应的关系。
World J Gastroenterol. 2005 Sep 28;11(36):5721-4. doi: 10.3748/wjg.v11.i36.5721.
8
Epidemiology and natural history of hepatitis B.乙型肝炎的流行病学与自然史
Semin Liver Dis. 2005;25 Suppl 1:3-8. doi: 10.1055/s-2005-915644.
9
Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.人类白细胞抗原II类基因与慢性乙型肝炎易感性或抗性之间的关联
World J Gastroenterol. 2003 Oct;9(10):2221-5. doi: 10.3748/wjg.v9.i10.2221.
10
A "NEW" ANTIGEN IN LEUKEMIA SERA.白血病血清中的一种“新”抗原。
JAMA. 1965 Feb 15;191:541-6. doi: 10.1001/jama.1965.03080070025007.